D. Western Therapeutics Institute
4576
Needs Well
3992
Daiwa Cycle
5888
Osaka Yuka Industry
4124
Liberta
4935
(FY)May 31, 2024 | (FY)May 31, 2023 | (FY)May 31, 2022 | (FY)May 31, 2021 | |
---|---|---|---|---|
Total revenue | -1.73%11.98B | 5.69%12.19B | -11.18%11.54B | 12.99B |
Cost of revenue | -2.97%9.08B | 4.87%9.36B | -11.52%8.92B | 10.08B |
Gross profit | 2.38%2.9B | 8.49%2.84B | -10.01%2.61B | 2.91B |
Operating expense | 2.61%2.5B | 1.30%2.44B | -12.21%2.4B | 2.74B |
Operating profit | 0.96%404.9M | 90.82%401.07M | 26.20%210.18M | 166.55M |
Net non-operating interest income (expenses) | 21.64%-14.21M | 11.31%-18.13M | 37.62%-20.44M | -32.77M |
Non-operating interest income | 19.36%15.1M | 7.18%12.65M | -6.12%11.8M | --12.57M |
Non-operating interest expense | -4.79%29.3M | -4.54%30.78M | -28.89%32.24M | --45.33M |
Net investment income | 6.87M | -61.01%3.83M | 9.82M | |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||
Gain(Loss) on derecognition of available-for-sale financial assets | 36.26M | 0 | 105.06%1.79M | -35.4M |
Income from associates and other participating interests | -77.60%2.76M | 50.62%12.34M | -29.57%8.19M | 11.63M |
Special income (charges) | 85.59%-35.74M | -36,263.49%-248M | -11.80%-682K | -610K |
Less:Restructuring and mergern&acquisition | ---10.31M | --0 | ---- | ---- |
Less:Other special charges | -92.04%9.5M | 2,780.81%119.32M | 81.79%-4.45M | ---24.44M |
Less:Write off | -71.59%36.56M | 2,406.84%128.68M | -79.51%5.13M | --25.05M |
Other non-operating income (expenses) | 38.99%4.95M | -44.55%3.56M | -54.65%6.42M | 14.17M |
Income before tax | 169.03%405.8M | -27.93%150.84M | 56.90%209.3M | 133.4M |
Income tax | 180.09%139.46M | -40.04%49.79M | 62.00%83.05M | 51.26M |
Net income | 163.58%266.34M | -19.97%101.05M | 53.72%126.25M | 82.13M |
Net income continuous operations | 163.58%266.34M | -19.97%101.05M | 53.72%126.25M | --82.13M |
Noncontrolling interests | 139.27%3.03M | -229.76%-7.72M | -4.82%5.95M | 6.25M |
Net income attributable to the company | 142.08%263.31M | -9.59%108.77M | 58.55%120.3M | 75.88M |
Preferred stock dividends | ||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 142.08%263.31M | -9.59%108.77M | 58.55%120.3M | 75.88M |
Gross dividend payment | ||||
Basic earnings per share | 142.34%637.34 | -9.59%262.99 | 58.54%290.87 | 183.4623 |
Diluted earnings per share | 142.34%637.34 | -9.59%262.99 | 68.43%290.87 | 172.6955 |
Dividend per share | 20.00%60 | 0.00%50 | 50 | |
Currency Unit | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |